Moderna Inc (MRNA)

Moderna Inc. stock outperforms competitors on strong trading day - MarketWatch

MarketWatch

Moderna's Coffee Break Science social media series brews up biopharma buzz - MM+M Online

MM+M Online

Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY

Zacks Investment Research

Moderna (NASDAQ:MRNA) Upgraded by Evercore ISI to Hold - Defense World

Defense World

Evercore ISI Initiates Coverage on Moderna (NASDAQ:MRNA) - Defense World

Defense World

Moderna Japan aiming for combined COVID-flu mRNA vaccine clinical trials this winter - MSN

MSN

The Operation Warp Speed Story Worsens By the Day - RealClearMarkets

RealClearMarkets

Moderna Inc. stock rises Wednesday, still underperforms market - MarketWatch

MarketWatch

Moderna Q1: A Promising Pipeline Is Undervalued (NASDAQ:MRNA) - Seeking Alpha

Seeking Alpha

Jim Cramer: This Industrial Company Is ‘Absolutely Terrific’, Recommends Buying Modine Manufacturing - Mo - Benzinga

Benzinga

Evercore ISI Group Initiates Coverage of Moderna (MRNA) with In-Line Recommendation - MSN

MSN

Moderna Japan aiming for combined COVID-flu mRNA vaccine clinical trials this winter - The Mainichi - The Mainichi

The Mainichi

Cramer's Lightning Round: 'I'm a believer' in Moderna - CNBC

CNBC

Moderna Inc. stock outperforms competitors on strong trading day - MarketWatch

MarketWatch

Teacher Retirement System of Texas Sells 10,124 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

MarketBeat

Moderna Stock Rebounds From Its RSV Fallout — Is It A Buy, Again? - Investor's Business Daily

Investor's Business Daily

Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility

Zacks Investment Research

Stock Market News for May 14, 2024

Zacks Investment Research

Apollon Wealth Management LLC Sells 3388 Shares of Moderna, Inc. (NASDAQ:MRNA) - Defense World

Defense World

Teacher Retirement System of Texas Trims Position in Moderna, Inc. (NASDAQ:MRNA) - Defense World

Defense World

Is This a Setback for Moderna?

The Motley Fool

Natixis Advisors L.P. Has $2.45 Million Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - Defense World

Defense World

Spire Wealth Management Cuts Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - Defense World

Defense World

As 'Roaring Kitty' Returns, Here Are 3 ETFs To Leverage The 2024 Meme Stock Wave

Benzinga

US FDA's Delay In Acting On Moderna RSV Vaccine Adds To Growing List of User Fee Goal Misses - Pink Sheet

Pink Sheet

Moderna Inc. stock outperforms competitors on strong trading day - MarketWatch

MarketWatch

Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal

Zacks Investment Research

Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine

Zacks Investment Research

Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine - Zacks Investment Research

Zacks Investment Research

Company News For May 13, 2024 - Yahoo Finance

Yahoo Finance

Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know - Yahoo Finance

Yahoo Finance

Bull Market and Beyond: 2 Stocks Just Waiting to Soar

The Motley Fool

Moderna to Present at Upcoming Conferences in May/June 2024 - Sacramento Bee

Sacramento Bee

2278 Shares in Moderna, Inc. (NASDAQ:MRNA) Acquired by Fisher Asset Management LLC - Defense World

Defense World

FDA delays decision on Moderna's RSV vaccine - pharmaphorum

pharmaphorum

U.S. inks $1.5 billion deal with Moderna for 100 million doses of COVID-19 vaccine - Yahoo Singapore News

Yahoo Singapore News

Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?

The Motley Fool

FDA review of Moderna's RSV vaccine delayed to late May - Investing.com Nigeria

Investing.com Nigeria

U.S. grants full approval to Moderna's COVID vaccine in adults - Yahoo Canada Shine On

Yahoo Canada Shine On

Moderna, Inc. (NASDAQ:MRNA) Director Sells $1,825,200.00 in Stock - MarketBeat

MarketBeat

Moderna Inc. stock underperforms Friday when compared to competitors - MarketWatch

MarketWatch

Moderna's RSV Vaccine Candidate Review Delayed — Precision Vaccinations News - Precision Vaccinations

Precision Vaccinations

Moderna, Inc. (NASDAQ:MRNA) Stake Boosted by Intrinsic Value Partners LLC - MarketBeat

MarketBeat

Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday? (CORRECTED)

Benzinga

Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday?

Benzinga

FDA delays decision date for Moderna's RSV vaccine - The Business Journals

The Business Journals

Moderna: FDA postpones RSV vaccine approval - Yahoo Finance

Yahoo Finance

US drug regulator delaying decision on RSV vaccine approval, says Moderna - Business Standard

Business Standard

Moderna says FDA will not complete review of RSV vaccine by May 12 deadline - Morningstar

Morningstar

US FDA pushes decision on Moderna's RSV vaccine to end of this month - Reuters

Reuters